Societal CDMO Inc logo

Societal CDMO Inc (SCTL)

Market Closed
5 Apr, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 10
+0.01
+0.9174%
$
116.13M Market Cap
- P/E Ratio
- Div Yield
512,703 Volume
-0.09 Eps
$ 1.09
Previous Close
Add Transaction
Day Range
1.09 1.1
Year Range
0.26 1.28
Want to track SCTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SCTL closed Friday higher at $1.1, an increase of 0.9174% from Thursday's close, completing a monthly increase of 0% or $1.1. Over the past 12 months, SCTL stock gained 0%.
SCTL is not paying dividends to its shareholders.
The last earnings report, released on Mar 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Societal CDMO Inc has completed 3 stock splits, with the recent split occurring on Mar 06, 2020.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

SCTL Chart

People also search for

Hudson Technologies Inc.
$ 5.7
+1.8767%
ACB
Aurora Cannabis Inc.
$ 2.89
-3.3445%
Soluna Holdings Inc.
$ 1.2
+2.5641%
Journey Medical Corp
$ 6.44
+0.1555%
PFSweb Inc
$ 7.5
+0.0668%

Societal CDMO Inc (SCTL) FAQ

What is the stock price today?

The current price is $1.10.

On which exchange is it traded?

Societal CDMO Inc is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is SCTL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 116.13M.

Has Societal CDMO Inc ever had a stock split?

Societal CDMO Inc had 3 splits and the recent split was on Mar 06, 2020.

Societal CDMO Inc Profile

Specialty Retail Industry
Consumer Discretionary Sector
J. David Enloe Jr. CEO
NASDAQ (CM) Exchange
75629F109 CUSIP
US Country
258 Employees
- Last Dividend
22 Nov 2019 Last Split
7 Mar 2014 IPO Date

Overview

Societal CDMO, Inc., previously known as Recro Pharma, Inc., is a recognized contract development and manufacturing organization (CDMO) that focuses on the creation, production, and packaging of various therapeutic dosage forms, predominantly for small molecules. The corporation offers its extensive services both within the United States and on an international scale. Having undergone a name change in March 2022, Societal CDMO, Inc. traces its origins back to 2007 and has its headquarters situated in Exton, Pennsylvania. The company's expertise in navigating regulatory requirements, alongside their comprehensive end-to-end service offerings, positions them as a key partner in the pharmaceutical industry, from the early stages of drug development to final product release.

Products and Services

  • Formulation Development: Focuses on complex formulations, reformulation, physical characterization, and excipient compatibility. This service aims to address the challenges of drug formulation, ensuring that medications are developed for optimal delivery and efficacy.
  • Analytical Methods Development: Offers a broad spectrum of analytical testing capabilities which include product testing, ICH stability, method development and validation, equipped with advanced chromatography and spectroscopy equipment, stability chambers, and resources for microbial testing. These analytical services are crucial for ensuring drug safety and efficacy throughout the development process.
  • Pharmaceutical Manufacturing: Provides an extensive range of manufacturing processes such as milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services. This comprehensive manufacturing capability allows for the production of pharmaceuticals across a variety of dosage forms, meeting stringent quality standards.
  • Regulatory Support: Includes handling communications with the Food and Drug Administration (FDA) and seeking consultation and guidance for client FDA meetings and responses. This support is vital for navigating the complex regulatory landscape, ensuring compliance and facilitating market entry.
  • Pharmaceutical Packaging and Logistics: Offers smaller-scale primary and secondary packaging, labeling, and kitting options suited for clinical trial materials and development packaging needs across dosage forms. Efficient packaging and logistics are essential for the safe and effective distribution of pharmaceuticals.

Contact Information

Address: 1 E. Uwchlan Ave
Phone: 770 534 8239